Status:
COMPLETED
Experimental Study to Validate the Modified Glucose Disposal Test
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Diabetes
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
Evaluate the modified GDT as a measure of key metabolic characteristics in healthy subjects and those with type 2 diabetes mellitus
Eligibility Criteria
Inclusion
- Clinical diagnosis of Type 2 diabetes
- Clinically healthy
- Drug naive or on a stable dose of metformin monotherapy and/or a secretagogue
Exclusion
- Type 1 Diabetes
- History of significant heart disease.
- Bariatric surgery
- Exposure to fibrates, thiazolidinediones, insulin, exenatide, pramlintide or DPP-IV inhibitors
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT01152372
Start Date
June 1 2010
End Date
November 1 2010
Last Update
February 23 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Profil Institute For Clinical Research, Inc. (Picr)
Chula Vista, California, United States, 91911